By REUTERS
The results, though not conclusive, provide the first evidence that targeting a protein known as PCSK9 could reduce cardiovascular risks for millions of patients.
Published: September 1, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1r0lniL
from WordPress http://ift.tt/1tmFiej
via Hadi Aboukhater
No comments:
Post a Comment